alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 313.13 Exception to opt out requirements for service providers and joint marketing. ( a ) *General rule.* ( 1 ) The opt out requirements in §§ 313.7 and 313.10 do not apply when you provide nonpublic personal information to a nonaffiliated third party to perform services for you or functions on your behalf, if you: ( i ) Provide the initial notice in accordance with § 313.4; and
( ii ) Enter into a contractual agreement with the third party that prohibits the third party from disclosing or using the information other than to carry out the purposes for which you disclosed the information, including use under an exception in § 313.14 or § 313.15 in the ordinary course of business to carry out those purposes.
( 2 ) *Example.* If you disclose nonpublic personal information under this section to a financial institution with which you perform joint marketing, your contractual agreement with that institution meets the requirements of paragraph (a)(1)(ii) of this section if it prohibits the institution from disclosing or using the nonpublic personal information except as necessary to carry out the joint marketing or under an exception in § 313.14 or § 313.15 in the ordinary course of business to carry out that joint marketing.
( b ) *Service may include joint marketing.* The services a nonaffiliated third party performs for you under paragraph (a) of this section may include marketing of your own products or services or marketing of financial products or services offered pursuant to joint agreements between you and one or more financial institutions.
( c ) *Definition of joint agreement.* For purposes of this section, joint agreement means a written contract pursuant to which you and one or more financial institutions jointly offer, endorse, or sponsor a financial product or service.
### §1395j. Establishment of supplementary medical insurance program for aged and disabled

There is hereby established a voluntary insurance program to provide medical insurance benefits in accordance with the provisions of this part for aged and disabled individuals who elect to enroll under such program, to be financed from premium payments by enrollees together with contributions from funds appropriated by the Federal Government.

(Aug. 14, 1935, ch. 531, title XVIII, §1831, as added Pub. L. 89–97, title I, §102(a), July 30, 1965, 79 Stat. 301; amended Pub. L. 92–603, title II, §201(a)(3), Oct. 30, 1972, 86 Stat. 1371.)

#### **Editorial Notes**

#### Amendments

1972—Pub. L. 92–603 substituted "aged and disabled individuals" for "individuals 65 years of age or over".

#### **Statutory Notes and Related Subsidiaries**

#### Study Regarding Coverage Under Part B of Medicare for Nonreimbursable Services Provided by Optometrists for Prosthetic Lenses for Patients With Aphakia

Pub. L. 94–182, title I, §109, Dec. 31, 1975, 89 Stat. 1053, provided that the Secretary of Health, Education, and Welfare conduct a study on the appropriateness of reimbursement under the insurance program established by this part for services performed by optometrists with respect to the provision of prosthetic lenses for patients with aphakia and submit such study to Congress not later than 4 months after Dec. 31, 1975.

#### Study To Determine Feasibility of Inclusion of Certain Additional Services Under Part B

Pub. L. 90–248, title I, §141, Jan. 2, 1968, 81 Stat. 855, directed Secretary to conduct a study relating to inclusion under the supplementary medical insurance program under this part of services of additional types of licensed practitioners performing health services in independent practice and submit such study to Congress prior to Jan. 1, 1969.
United States
                       SECURITIES AND EXCHANGE COMMISSION
                                Washington, D.C.

                                    FORM 8-K

                                 CURRENT REPORT


     Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported) August 27, 1997


                     Coastal Caribbean Oils & Minerals, Ltd.
             (Exact name of registrant as specified in its charter)


          Bermuda                       1-4668                      NONE
State or other jurisdiction          (Commission               (IRS Employer
     of incorporation)               File Number)            Identification No.)


Clarendon House, Church Street, Hamilton HM DX, BERMUDA             NONE
        (Address of principal executive offices)                 (Zip Code)


        Registrant's telephone number, including area code (441) 295-1422


         (Former name or former address, if changed since last report.)



<PAGE>


                                                        
                                    FORM 8-K

                     COASTAL CARIBBEAN OILS & MINERALS, LTD.





Item 5.   Other Events

          Coastal Petroleum  Company,  the Company's  majority owned subsidiary,
advised the State of Florida that its petroleum  consultants  have evaluated the
offshore St. George Island  prospect and have estimated the structure to contain
2.19 billion barrels of oil in place with 546 million barrels  recoverable.  The
Company disclosed  this  evaluation in connection with a pending drilling permit
application to test the prospect

         A press release  relating to this  development  is filed herewith as an
exhibit and incorporated herein by reference.

Item 7.   Financial Statements, Pro Forma Financial Information and
          Exhibits

          (c)  Exhibits

               (99)  Additional Exhibits

                     (a)  Press release of the registrant dated August 27, 1997.



<PAGE>


                                                         



                                   SIGNATURES


          Pursuant to the  requirements of the Securities  Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                         COASTAL CARIBBEAN OILS & MINERALS, LTD.
                                                     (Registrant)



                                         By /s/ Benjamin W. Heath
                                                Benjamin W. Heath
                                                President


Date:  September 2, 1997
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Antitrust Division

                    Notice is hereby given that, on September 17, 2004, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301*et seq.*                     (“the Act”), DICOM Standards Committee (“DICOM”), by its Secretariat, the National Electrical Manufacturers Association (“NEMA”), has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing (1) the name and principal place of business of the standards development organization and (2) the nature and scope of its standards development activities. The notifications were filed for the purpose of invoking the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances.                

Pursuant to section 6(b) of the Act, the name and principal place of business of the standards development organization is: DICOM Standards Committee, Rosslyn, VA. The nature and scope of DICOM's standards development activities are: To develop and maintain the DICOM (“Digital Communications in Medicine”) Standard, an international standard for communication of biomedical diagnostic and therapeutic information in disciplines that use digital images and associated data. The goals of DICOM are to achieve compatibility and to improve workflow efficiency between imaging systems and other information systems in healthcare environments worldwide. The standards developed by DICOM are published by NEMA.

Dorothy B. Fountain,

Deputy Director of Operations, Antitrust Division.

[FR Doc. 04-26623 Filed 12-2-04; 8:45 am]

BILLING CODE 4410-11-M
Home > NRC Library > ADAMS Public Documents

# SECY-12-0125 - Interim Actions to Execute Commission Preemption Authority Under Section 161 A of the Atomic Energy Act of 1954, as amended

Accession Number: ML12164A839

Date Released: Friday, October 5, 2012

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.
    - ML12171A089 - SECY-12-0125 - INTERIM ACTIONS TO EXECUTE COMMISSION PREEMPTION AUTHORITY UNDER SECTION 161A OF THE ATOMIC ENERGY ACT OF 1954, AS AMENDED (7 page(s), 9/20/2012)
    - ML12171A108 - SECY-12-0125 - Enclosure 1 - Draft Order (8 page(s), 9/20/2012)
    - ML12171A120 - SECY-12-0125 - Enclosure 2 - Draft Confirmatory Order Modifying License (8 page(s), 9/20/2012)

Privacy PolicySite Disclaimer
#### §§ 23.441-23.449 [Reserved]
###### Editorial Note on Part 200

#### Editorial Note:

Nomenclature changes to part 200 appear at 76 FR 60371, Sept. 29, 2011.

#### § 200.57 Relationships with other members.

Each member should recognize that his conscience and those of other members are distinct entities and that differing shades of opinion should be anticipated. The free expression of opinion is a safeguard against the domination of this Commission by less than a majority, and is a keystone of the commission type of administration. However, a member should never permit his personal opinion so to conflict with the opinion of another member as to develop animosity or unfriendliness in the Commission, and every effort should be made to promote solidarity of conclusion.
Clorox Completes Acquisition of Armor All Products Corporation

Oakland, Calif., Jan. 2, 1997 -- The Clorox Company (CLX - NY, 
PSE) and Armor All Products Corporation  (ARMR - NASDAQ) today 
announced the merger of Clorox's wholly owned subsidiary, 
Shield Acquisition Corporation, with and into Armor All. 
Shield Acquisition Corporation was established by Clorox to 
execute the Armor All acquisition.

The merger follows upon the completion of Clorox's tender offer 
for all of the outstanding shares of Armor All announced on 
Dec. 31, 1996. Those stockholders of Armor All who have not 
tendered their shares pursuant to the tender offer have the 
right to receive $19.09 net per share.

Contacts:

News Media --Mark Marymee, (510) 271-7461
Investment Community -- Karen Rose, (510) 271-7385;
                        Ughetta Ugolini (510) 271-2270
United States
                       SECURITIES AND EXCHANGE COMMISSION
                                Washington, D.C.

                                    FORM 8-K

                                 CURRENT REPORT


     Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported) January 28, 1998


                     Coastal Caribbean Oils & Minerals, Ltd.
             (Exact name of registrant as specified in its charter)


         Bermuda                         1-4668                     NONE
State or other jurisdiction           (Commission               (IRS Employer
    of incorporation)                 File Number)           Identification No.)


Clarendon House, Church Street, Hamilton HM DX, BERMUDA             NONE
         (Address of principal executive offices)               (Zip Code)


        Registrant's telephone number, including area code (441) 295-1422


         (Former name or former address, if changed since last report.)



<PAGE>


                                                         
                                    FORM 8-K

                     COASTAL CARIBBEAN OILS & MINERALS, LTD.





Item 5.   Other Events

         On January 28, 1998,  the Florida  Supreme  Court refused to review the
First District Court of Appeal's denying Coastal Petroleum Company's  claim that
a compensatory taking of its royalty interest acreage had occurred.

         A press release relating to these  developments is filed herewith as an
exhibit and incorporated herein by reference.

Item 7.   Financial Statements, Pro Forma Financial Information and
          Exhibits

          (c)  Exhibits

               (99)  Additional Exhibits

                     (a) Press release of the registrant dated January 30, 1998.



<PAGE>


                                                       



                                   SIGNATURES


          Pursuant to the  requirements of the Securities  Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                         COASTAL CARIBBEAN OILS & MINERALS, LTD.
                                                        (Registrant)



                                         By /s/ Benjamin W. Heath
                                                Benjamin W. Heath
                                                President

Date:  January 30, 1998
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3928 Introduced in House (IH)]

112th CONGRESS
  2d Session
                                H. R. 3928

            To suspend temporarily the duty on 1H-Xantheno.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 7, 2012

   Mr. Watt introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
            To suspend temporarily the duty on 1H-Xantheno.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. 1H-XANTHENO.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      (1H-Xantheno[2,1,9- Free         No change        No change        On or before 12/  ''.
                        def]isoquinoline-                                                  31/2014.......
                        5,9-disulfonic
                        acid, 2,3-dihydro-
                        1,3-dioxo-2-[3-
                        [[2-(sulfooxy)
                        ethyl]sulfonyl]ph
                        enyl]-, sodium
                        salt (1:3)) (CAS
                        No. 444087-59-6)
                        (provided for in
                        subheading
                        3204.16.30)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to articles entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
##### 



Exhibit 32.2 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 The undersigned, the Chief Financial Officer of Gladstone Commercial
Corporation (the Company), hereby certifies on the date hereof, pursuant to
18 U.S.C. §1350(a), as adopted pursuant to Section 906 of The Sarbanes-Oxley
Act of 2002, that the Quarterly Report on Form 10-Q for the quarter ended June
30, 2004 (Form 10-Q), filed concurrently herewith by the Company, fully
complies with the requirements of Section 13(a) or Section 15(d) of the
Securities Exchange Act of 1934, as amended, and that the information contained
in the Form 10-Q fairly presents, in all material respects, the financial
condition and results of operations of the Company. Dated: August 4, 2004 /s/ Harry Brill
#### § 201.523 [Reserved]
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3971 Introduced in House (IH)]

112th CONGRESS
  2d Session
                                H. R. 3971

    To suspend temporarily the duty on mixtures of Reactive Blue 19.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 7, 2012

   Mr. Watt introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
    To suspend temporarily the duty on mixtures of Reactive Blue 19.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. MIXTURES OF REACTIVE BLUE 19.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      Mixtures of         Free         No change        No change        On or before 12/  ''.
                        Reactive Blue 19,                                                  31/2014.......
                        (2-
                        Anthracenesulfoni
                        c acid, 1-amino-
                        9,10-dihydro-9,10-
                        dioxo-4-[[3-[[2-
                        (sulfooxy)
                        ethyl]sulfonyl]ph
                        enyl]amino]-,
                        sodium salt
                        (1:2)), (CAS No.
                        2580-78-1) and
                        (Pyridinium, 1,1'-
                        [(6,13-dichloro-
                        4,11-disulfo-3,10-
                        triphenodioxazine
                        diyl)bis[imino-
                        2,1-
                        ethanediylimino[6-
                        [(2,5-
                        disulfophenyl)ami
                        no]-1,3,5-
                        triazine-4,2-
                        diyl]]]bis[3-
                        carboxy-,
                        bis(inner salt),
                        sodium salt
                        (1:6)) (CAS No.
                        79771-28-1)
                        (provided for in
                        subheading
                        3204.16.30)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to articles entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
<PAGE>

                                                                   EXHIBIT 10.19

NON-EMPLOYEE DIRECTORS' COMPENSATION

In fiscal 2006, non-employee directors will receive compensation of $1,000 per
month for Board membership and $1,000 for each Board meeting attended and will
be reimbursed for out of pocket expenses in connection with attending a Board
meeting. Committee members will receive additional compensation of $750 for each
Audit and/or Compensation Committee meeting attended, with no additional
compensation paid for service on the Nominating and Governance Committee. The
chairman of the Board will receive an annual stipend of $4,000 per year, and the
chairs of the Audit and Compensation Committees will each receive an annual
stipend of $2,000.

Directors who are otherwise employees of the Company do not receive any
additional compensation for their service on the Board or any of its committees.
### §16394. Outreach

The Secretary shall ensure that each program authorized by this Act or an amendment made by this Act includes an outreach component to provide information, as appropriate, to manufacturers, consumers, engineers, architects, builders, energy service companies, institutions of higher education, facility planners and managers, State and local governments, and other entities.

(Pub. L. 109–58, title X, §1004, Aug. 8, 2005, 119 Stat. 930.)

#### **Editorial Notes**

#### References in Text

This Act, referred to in text, is Pub. L. 109–58, Aug. 8, 2005, 119 Stat. 594, known as the Energy Policy Act of 2005, which enacted this chapter and enacted, amended, and repealed numerous other sections and notes in the Code. For complete classification of this Act to the Code, see Short Title note set out under section 15801 of this title and Tables.
#### § 170.2 Membership restrictions (section 17(b)(2) of the Act).

If it appears to the Commission to be necessary or appropriate in the public interest and to carry out the purposes of section 17 of the Act, a futures association may restrict its membership to individuals registered by the Commission in a particular capacity or to individuals doing business in a particular geographical region or to firms having a particular level of capital assets or which engage in a specified amount of business per year.

[48 FR 35305, Aug. 3, 1983]
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3e35bbe8-3d22-4568-ae17-aac984629281,g:ca2c3aa0-b4b8-44ef-81df-e3a0feef715e-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cna="http://www.cna.com/20220310" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cna.com/20220310">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cna-20220310_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cna-20220310_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cna-20220310_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPageCoverPage" roleURI="http://www.cna.com/role/CoverPageCoverPage">
        <link:definition>0001001 - Document - Cover Page Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>